Search research articles
Contact Us
Filters
Showing results (101-110 of 191) with videos related to
Page
of 20
Sort By:
Journal of Biomaterials Science. Polymer Edition
|
May 31, 2011
Hydrogels Containing Core Cross-Linked Block Co-Polymer Micelles
Changhai Lu, Andrew S Mikhail, Xinyue Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 13, 2012
Neoplastic cell response to tiopronin-coated gold nanoparticles
Lei Cui, Payam Zahedi, Justin Saraceno, et al.
Molecular Pharmaceutics
|
September 23, 2015
Effects of Doxorubicin Delivery Systems and Mild Hyperthermia on Tissue Penetration in 3D Cell Culture Models of Ovarian Cancer Residual Disease
Sina Eetezadi, Raquel De Souza, Mirugashini Vythilingam, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 19, 2021
Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel
Jack Bufton, Sungmin Jung, James C Evans, et al.
Advanced Drug Delivery Reviews
|
May 21, 2021
Machine learning directed drug formulation development
Pauric Bannigan, Matteo Aldeghi, Zeqing Bao, et al.
Molecular Pharmaceutics
|
August 9, 2013
Continuous intraperitoneal carboplatin delivery for the treatment of late-stage ovarian cancer
Nickholas Zhidkov, Raquel De Souza, Amir H Ghassemi, et al.
International Journal of Molecular Sciences
|
May 24, 2019
Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
Yen Ting Shen, Lucy Wang, James C Evans, et al.
Data in Brief
|
March 23, 2023
Data evaluating triamcinolone acetonide and triamcinolone hexacetonide loaded poly(δ-valerolactone-<i>co</i>-allyl-δ-valerolactone) microparticles
Zeqing Bao, Sungmin Jung, Jack Bufton, et al.
Molecular Cancer Therapeutics
|
May 10, 2011
Chemotherapy dosing schedule influences drug resistance development in ovarian cancer
Raquel De Souza, Payam Zahedi, Rose M Badame, et al.
Plos One
|
May 30, 2013
Estrone-3-sulphate, a potential novel ligand for targeting breast cancers
Nilasha Banerjee, Humphrey Fonge, Andrew Mikhail, et al.
Page
of 20
Search research articles
Search
Showing results (101-110 of 191) with videos related to
Sort By:
Page
of 20
Journal of Biomaterials Science. Polymer Edition
|
May 31, 2011
Hydrogels Containing Core Cross-Linked Block Co-Polymer Micelles
Changhai Lu, Andrew S Mikhail, Xinyue Wang, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
June 13, 2012
Neoplastic cell response to tiopronin-coated gold nanoparticles
Lei Cui, Payam Zahedi, Justin Saraceno, et al.
Molecular Pharmaceutics
|
September 23, 2015
Effects of Doxorubicin Delivery Systems and Mild Hyperthermia on Tissue Penetration in 3D Cell Culture Models of Ovarian Cancer Residual Disease
Sina Eetezadi, Raquel De Souza, Mirugashini Vythilingam, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
March 19, 2021
Cross-linked valerolactone copolymer implants with tailorable biodegradation, loading and in vitro release of paclitaxel
Jack Bufton, Sungmin Jung, James C Evans, et al.
Advanced Drug Delivery Reviews
|
May 21, 2021
Machine learning directed drug formulation development
Pauric Bannigan, Matteo Aldeghi, Zeqing Bao, et al.
Molecular Pharmaceutics
|
August 9, 2013
Continuous intraperitoneal carboplatin delivery for the treatment of late-stage ovarian cancer
Nickholas Zhidkov, Raquel De Souza, Amir H Ghassemi, et al.
International Journal of Molecular Sciences
|
May 24, 2019
Development of a Bioluminescent BRCA1-Deficient Xenograft Model of Disseminated, High-Grade Serous Ovarian Cancer
Yen Ting Shen, Lucy Wang, James C Evans, et al.
Data in Brief
|
March 23, 2023
Data evaluating triamcinolone acetonide and triamcinolone hexacetonide loaded poly(δ-valerolactone-<i>co</i>-allyl-δ-valerolactone) microparticles
Zeqing Bao, Sungmin Jung, Jack Bufton, et al.
Molecular Cancer Therapeutics
|
May 10, 2011
Chemotherapy dosing schedule influences drug resistance development in ovarian cancer
Raquel De Souza, Payam Zahedi, Rose M Badame, et al.
Plos One
|
May 30, 2013
Estrone-3-sulphate, a potential novel ligand for targeting breast cancers
Nilasha Banerjee, Humphrey Fonge, Andrew Mikhail, et al.
Page
of 20